A comprehensive view of Over-the-Counter (OTC) Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Dollar General forms Healthcare Advisory Panel, a body of experts that will help explore ways to expand company's health care offerings; news comes after naming Dr. Albert Wu from McKinsey to newly created post of VP, chief medical officer last July

51% of US adults unlikely to use prescription drugs, OTC products after a recall, even if issue is fixed; 80% of adults unlikely to trust a manufacturer after warning letter from FDA, 47% unlikely to ever use a product from manufacturer again: Qualio

FDA announces Family Dollar retail stores recall of wide variety of OTC medications, personal care items nationwide because products may have been stored outside labeled temperature requirements; recall involves 425 individual products

Global OTC drug market projected to grow to US$410.5B by 2030, with CAGR growth of 8.2% from 2022-2030; growth driven by increased focus on maintaining health, use of OTC drugs to treat common illnesses

Teva swings to Q2 GAAP operating loss of US$949.0M from US$582.0M income last year, with revenues down 3% from a year ago to US$3.8B; generic, OTC business benefitted from easing of COVID-19 restrictions and firm reaches agreement in opioids litigation

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count